ATS Medical, Inc. (ATSI) Announces that Columbia University Medical Center Achieves 100 Implants of the ATS 3f(R) Aortic Bioprosthesis

ATS Medical, Inc. (Nasdaq: ATSI) announced that Columbia University Medical Center has achieved 100 implants of the ATS 3f(R) Aortic Bioprosthesis. ATS Medical(ATSI) is dedicated to "Advancing The Standards" of cardiac surgery through the development, manufacturing and marketing of innovative products and services for the treatment of structural heart disease. The Columbia University surgeons have utilized the ATS 3f Aortic Bioprosthesis predominantly in small aortic roots where conventional stented tissue valves lack a pronounced hemodynamic benefit.